Gene: POLM
Official Full Name: DNA polymerase muprovided by HGNC
Gene Summary: Predicted to enable DNA-directed DNA polymerase activity. Predicted to be involved in double-strand break repair via nonhomologous end joining. Predicted to act upstream of or within B cell differentiation and somatic hypermutation of immunoglobulin genes. Predicted to be located in nucleoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07313 | POLM Knockout cell line (HeLa) | Human | POLM | 1:3~1:6 | Negative | Online Inquiry |
KO07314 | POLM Knockout cell line (HCT 116) | Human | POLM | 1:2~1:4 | Negative | Online Inquiry |
KO07315 | POLM Knockout cell line (HEK293) | Human | POLM | 1:3~1:6 | Negative | Online Inquiry |
KO07316 | POLM Knockout cell line (A549) | Human | POLM | 1:3~1:4 | Negative | Online Inquiry |
POLM Gene Knockout Cell Lines represent a cutting-edge resource for the study of POLM (DNA polymerase mu), a critical enzyme involved in the repair of DNA and the maintenance of genomic stability. These cell lines are specifically engineered to lack the POLM gene, enabling researchers to explore the functional consequences of its absence on cellular processes such as DNA repair, cell cycle regulation, and apoptosis.
The key mechanism driving the utility of POLM Gene Knockout Cell Lines lies in their ability to model POLM deficiency. By providing researchers with a precise platform to examine the alterations in cellular behavior, signaling pathways, and mutations that occur in the absence of POLM, these cell lines facilitate an in-depth understanding of DNA damage response mechanisms. This can lead to insights into the etiology of various diseases, including cancer, where DNA repair pathways are often compromised.
In research and clinical settings, POLM knockout models are invaluable for drug testing and the development of targeted therapies. They enable scientists to assess how perturbations in DNA repair mechanisms affect the efficacy and safety of chemotherapeutic agents, thereby contributing to personalized medicine approaches. Furthermore, these models can be utilized in basic research to decipher gene interactions, providing a clearer picture of the cellular landscape during DNA damage and repair processes.
POLM Gene Knockout Cell Lines offer distinct advantages over traditional models, including their specificity in knocking out the POLM gene without introducing off-target effects, thus ensuring the integrity of experimental outcomes. Unlike other available models, these are ideally suited for exploring the unique role of POLM in both normal and pathological conditions, providing a focused approach to understanding its contributions.
For researchers and clinicians alike, the value of POLM Gene Knockout Cell Lines is underscored by their potential to unveil novel therapeutic targets and strategies. Understanding the molecular underpinnings related to POLM can drive innovations in treatment modalities for diseases associated with DNA damage.
Our company brings extensive expertise in the development of genetically modified cell lines, ensuring that researchers can rely on our products for both their robustness and reproducibility. By choosing POLM Gene Knockout Cell Lines, you gain access to a powerful tool that will enhance your research capabilities and contribute significantly to advancements in biomedical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.